Longitudinal study assesses myelin content changes in white matter, suggesting T1w/FLAIR-ratio is a valuable clinical metric.
Motivation: Conventional MRI is not sensitive enough to detect subtle changes in myelin content of patients with relapsing-remitting multiple sclerosis (RRMS). T1w/FLAIR-ratio was introduced to improve contrast for myelin content. Goal(s): Using T1w/FLAIR-ratio longitudinally to assess white matter (peri)lesion progression and changes in normal-appearing white matter (NAWM) in patients with RRMS, with correlations to expanded disability status scale (EDSS). Approach: T1w- and FLAIR-sequences, and clinical data will be collected retrospectively of approximately 50 patients with RRMS. Linear mixed effects models will be used to assess (peri)lesional and NAWM changes of the brain for correlations between the T1w/FLAIR-ratio and clinical measures. Impact: The T1w/FLAIR-ratio can potentially be a valuable metric to evaluate white matter changes in the myelin content. This study will investigate whether this myelin-proxy can provide estimates that can help predict progression of clinical symptoms in RRMS.
No takes yet. Share an insight, caveat, or question.
Boogaard et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: